Nuvalent Inc (NUVL)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
James R. Porter
Employees:
40
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE, MA 02142
508-446-2272

Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations.

Data derived from most recent annual or quarterly report
Market Cap 718.648 Million Shares Outstanding42.879 Million Avg 30-day Volume 131.638 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-3.17
Price to Revenue0.0 Debt to Equity0.0 EBITDA-65.052 Million
Price to Book Value2.5899 Operating Margin0.0 Enterprise Value398.243 Million
Current Ratio25.789 EPS Growth0 Quick Ratio25.604
1 Yr BETA 1.7124 52-week High/Low 40.82 / 7.09 Profit Margin0.0
Operating Cash Flow Growth-116.4929 Altman Z-Score38.8737 Free Cash Flow to Firm 0
Earnings Report2022-11-09
View SEC Filings from NUVL instead.

View recent insider trading info

Funds Holding NUVL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NUVL

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

23.1 Thousand total shares from 7 transactions

Exercise Derivative Conversion (M)

21 Thousand total shares from 4 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

NOCI DARLENE CHIEF DEVELOPMENT OFFICER

  • Officer
50,000 2022-08-01 5

SHAIR MATTHEW

  • Director
2,162,598 2022-07-13 2

FLYNN JAMES E

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

  • Director
  • 10% Owner
  • DIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATION
20,000 2022-06-16 1

PROTOPAPAS ANNA

  • Director
20,000 2022-06-16 3

SRIVASTAVA SAPNA

  • Director
20,000 2022-06-16 1

GILLILAND DWIGHT GARY

  • Director
20,000 2022-06-16 1

HACK ANDREW A. F.

  • Director
20,000 2022-06-16 1

WHEELER CAMERON

  • Director
20,000 2022-06-16 1

PEARLBERG JOSEPH

  • Director
20,000 2022-06-16 1

CONLEY EMILY

  • Director
20,000 2022-06-16 3

TURNER CHRISTOPHER DURANT CHIEF MEDICAL OFFICER

  • Officer
341,178 2022-05-17 2

BALCOM ALEXANDRA CHIEF FINANCIAL OFFICER

  • Officer
107,000 2022-01-04 1

PORTER JAMES RICHARD PRESIDENT AND CEO

  • Officer
  • Director
330,400 2022-01-04 1

MILLER DEBORAH ANN CHIEF LEGAL OFFICER

  • Officer
107,000 2022-01-04 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

NOCI DARLENE - Officer CHIEF DEVELOPMENT OFFICER

2022-08-02 16:46:57 -0400 2022-08-01 A 50,000 a 50,000 direct

NOCI DARLENE - Officer CHIEF DEVELOPMENT OFFICER

2022-07-19 17:01:24 -0400 2022-07-19 M 318 $1.08 a 318 direct yes 3.1407 7.2864 7.2864 6 -4.2085 3

NOCI DARLENE - Officer CHIEF DEVELOPMENT OFFICER

2022-07-19 17:01:24 -0400 2022-07-19 S 318 $17.02 d 0 direct yes 3.1407 7.2864 7.2864 6 -4.2085 3

NOCI DARLENE - Officer CHIEF DEVELOPMENT OFFICER

2022-07-19 17:01:24 -0400 2022-07-19 M 318 d 145,389 direct yes

NOCI DARLENE - Officer CHIEF DEVELOPMENT OFFICER

2022-07-19 17:01:24 -0400 2022-07-18 M 100 $1.08 a 100 direct yes 3.1407 7.2864 7.2864 6 -4.2085 3

NOCI DARLENE - Officer CHIEF DEVELOPMENT OFFICER

2022-07-19 17:01:24 -0400 2022-07-18 S 100 $17.07 d 0 direct yes 3.1407 7.2864 7.2864 6 -4.2085 3

NOCI DARLENE - Officer CHIEF DEVELOPMENT OFFICER

2022-07-19 17:01:24 -0400 2022-07-18 M 100 d 145,707 direct yes

SHAIR MATTHEW - Director

2022-07-15 16:51:22 -0400 2022-07-15 S 2,000 $18.29 d 2,162,598 direct yes 5.1703 -3.5888 5.1703 2 -7.2384 5

NOCI DARLENE - Officer CHIEF DEVELOPMENT OFFICER

2022-07-19 17:01:24 -0400 2022-07-15 M 3,782 $1.08 a 3,782 direct yes 3.1407 7.2864 7.2864 6 -4.2085 3

NOCI DARLENE - Officer CHIEF DEVELOPMENT OFFICER

2022-07-19 17:01:24 -0400 2022-07-15 S 3,482 $17.21 d 300 direct yes 3.1407 7.2864 7.2864 6 -4.2085 3

NOCI DARLENE - Officer CHIEF DEVELOPMENT OFFICER

2022-07-19 17:01:24 -0400 2022-07-15 S 300 $18.18 d 0 direct yes 3.1407 7.2864 7.2864 6 -4.2085 3

NOCI DARLENE - Officer CHIEF DEVELOPMENT OFFICER

2022-07-19 17:01:24 -0400 2022-07-15 M 3,782 d 145,807 direct yes

SHAIR MATTHEW - Director

2022-07-15 16:51:22 -0400 2022-07-13 S 100 $18.25 d 2,164,598 direct yes 5.1703 -3.5888 5.1703 2 -7.2384 5

NOCI DARLENE - Officer SEE REMARKS

2022-07-08 16:17:29 -0400 2022-07-07 M 16,800 $1.08 a 16,800 direct yes -2.1462 -4.6404 3.7123 4 -4.6404 6

NOCI DARLENE - Officer SEE REMARKS

2022-07-08 16:17:29 -0400 2022-07-07 S 16,800 $17.61 d 0 direct yes -2.1462 -4.6404 3.7123 4 -4.6404 6

NOCI DARLENE - Officer SEE REMARKS

2022-07-08 16:17:29 -0400 2022-07-07 M 16,800 d 149,589 direct yes

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
NUVALENT INC-A NUVL 2022-08-15 22:15:04 UTC -0.6131 2.9331 650000
NUVALENT INC-A NUVL 2022-08-15 21:45:04 UTC -0.6131 2.9331 650000
NUVALENT INC-A NUVL 2022-08-15 21:15:04 UTC -0.6131 2.9331 650000
NUVALENT INC-A NUVL 2022-08-15 20:45:04 UTC -0.609 2.929 650000
NUVALENT INC-A NUVL 2022-08-15 20:15:03 UTC -0.609 2.929 650000
NUVALENT INC-A NUVL 2022-08-15 19:45:04 UTC -0.609 2.929 650000
NUVALENT INC-A NUVL 2022-08-15 19:15:04 UTC -0.609 2.929 650000
NUVALENT INC-A NUVL 2022-08-15 18:45:04 UTC -0.6089 2.9289 650000
NUVALENT INC-A NUVL 2022-08-15 18:15:04 UTC -0.6089 2.9289 650000
NUVALENT INC-A NUVL 2022-08-15 17:45:04 UTC -0.6089 2.9289 650000
NUVALENT INC-A NUVL 2022-08-15 17:15:03 UTC -0.6089 2.9289 650000
NUVALENT INC-A NUVL 2022-08-15 16:45:04 UTC -0.6163 2.9363 650000
NUVALENT INC-A NUVL 2022-08-15 16:15:04 UTC -0.6163 2.9363 650000
NUVALENT INC-A NUVL 2022-08-15 15:45:04 UTC -0.6163 2.9363 50000
NUVALENT INC-A NUVL 2022-08-15 15:15:04 UTC -0.6163 2.9363 50000
NUVALENT INC-A NUVL 2022-08-15 14:45:04 UTC -0.6163 2.9363 45000
NUVALENT INC-A NUVL 2022-08-15 14:15:03 UTC -0.6163 2.9363 50000
NUVALENT INC-A NUVL 2022-08-15 13:45:04 UTC -0.5827 2.9027 50000
NUVALENT INC-A NUVL 2022-08-15 13:15:04 UTC -0.5827 2.9027 25000
NUVALENT INC-A NUVL 2022-08-15 12:45:04 UTC -0.5827 2.9027 25000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund NUVL -1600.0 shares, $-22224.0 2022-03-31 N-PORT

Elevate your investments